Tirzepitide 30mg
Tirzepitide 30mg
Tirzepatide is a once-weekly dual GIP and GLP-1 receptor agonist researched in type 2 diabetes, chronic weight management and cardiometabolic outcomes.
R1 550,00
In stock
product description
Tirzepitide 30mg
Tirzepitide – Product Description
A once-weekly dual GIP and GLP-1 receptor agonist. Approved tirzepatide medicines have defined indications for type 2 diabetes and chronic weight management, subject to local regulation and prescribing requirements.
Research benefits:
– Produced substantial and sustained weight reduction in phase 3 trials
– Improves glycaemic control in people with type 2 diabetes
– Studied for appetite and energy-intake regulation
– Improved multiple cardiometabolic measures in trials
– Provides an established dual-incretin research model
Research references:
https://pubmed.ncbi.nlm.nih.gov/35658024/
https://pubmed.ncbi.nlm.nih.gov/37385275/
https://pubmed.ncbi.nlm.nih.gov/38078870/
related Peptide products
R600,00
R900,00
R1 900,00
product reviews
IMPORTANT DISCLAIMER:
Content on this website is for informational purposes only and does not constitute medical advice. Products are sold for research purposes only and are not intended for human or animal use.
Consult a registered healthcare professional before making health-related decisions.
Nationwide delivery
We ship nationwide with reliable couriers directly to your door.
Research Backed
We offer a research-backed selection of high-quality Peptides.
Secure payments
Payments are processed by a trusted online payment provider.
Reviews
There are no reviews yet.